Where Peptide Impurities Come From: Deletion, Truncation, Oxidation and Aggregation
Purity tells you what fraction of a sample is the intended peptide. What it never tells you is the identity of the rest, and that silence is consequential, because the rest is not arbitrary. Impurities in synthetic peptides arise from a short list of well-characterized processes, and each one leaves behind a recognizable signature. Working out which process generated a given peak is what separates a cosmetic blemish from a reason to reject the lot.
Below, those processes and the mark each leaves on an analytical report. The reports themselves are covered in reading a certificate of analysis and reading an HPLC chromatogram.
The assembly process, and its failure points
Solid-phase synthesis assembles a chain residue by residue on a resin support. A cycle strips the protecting group from the free end of the growing chain, couples on the next protected amino acid, and washes out whatever failed to react. Building 15 residues therefore means about fifteen deprotection and coupling cycles, followed by cleavage off the resin and removal of side-chain protecting groups.
Each impurity class described here is a particular step failing. It also explains why impurity profiles repeat: hold the sequence and the process constant and the synthesis tends to break down at the same point every time.
A residue missing from the middle
When a coupling cycle falls short of completion, a portion of the resin-bound chains never receive that residue at all. Synthesis proceeds on them anyway, producing a peptide short one internal amino acid, which is what a deletion sequence is.
Mass spectrometry makes these obvious once you know the pattern: the observed mass falls below target by precisely the residue mass of whatever was skipped. Glycine takes off 57, alanine 71, proline 97, valine 99, leucine and isoleucine 113 apiece, phenylalanine 147, tryptophan 186. Find a peak 97 below target in a proline-rich sequence and a proline deletion is the only explanation that fits cleanly.
These deserve attention because a peptide lacking one internal residue can resemble the target closely enough to co-elute with it while differing enough to alter an experimental result. Of all the impurity classes, this is the one a purity percentage conceals most easily.
Losses from the ends
Truncation removes material from a terminus rather than from the interior. It happens when synthesis halts outright on some share of the chains, or when a terminal residue is lost during cleavage and deprotection.
Chromatographic resolution is generally better for truncated species than for deletions, since removing a terminal residue, especially a hydrophobic one, moves retention appreciably. The mass spectrum gives a further clue: truncation produces a series rather than one peak, each member one residue mass below the one before. A ladder of masses means truncation; an isolated low mass more likely means a deletion.
Protecting groups that stayed on
Side-chain protecting groups are supposed to be removed at the end of the process. Any that survive leave a peptide with the correct sequence carrying extra chemistry, so the mass comes out above the target instead of below it.
Each of the common groups adds a characteristic increment, and a peak sitting above target by an amount matching one of them indicates a deprotection failure rather than an outside contaminant. Such species tend to be markedly more hydrophobic than the target and elute later, which makes a trailing shoulder on a reverse-phase trace worth testing against this explanation.
Oxidation, the one that happens later
Alone among these classes, oxidation can develop after the peptide leaves the synthesizer, which makes it a handling and storage question rather than a manufacturing one.
Methionine oxidizes most readily of all: the sulfur picks up an oxygen to form the sulfoxide, adding 16 to the mass. Cysteine oxidizes into disulfide bridges, either within a chain or linking two chains together. Tryptophan resists longer but does eventually oxidize, yielding several possible products.
Any sequence containing methionine, cysteine or tryptophan therefore has this route open to it, and material that analyzed clean at the point of manufacture can acquire an oxidation peak in storage after exposure to air, light or warmth. The textbook case is a mass 16 above target in a methionine-containing peptide. The driving conditions are covered in our note on how peptides degrade.
Amide side chains that hydrolyze
Asparagine and glutamine can shed their side-chain amide and convert to aspartate and glutamate, gaining 1 in mass and changing charge in the process. Rate depends heavily on the neighboring residue and on pH, and it runs faster in solution than in the dry state, which is one reason material is shipped and stored lyophilized.
Since a mass difference of 1 sits right at the limit of low-resolution instrumentation, chromatography frequently exposes deamidation more clearly than mass does. The deamidated species picks up an extra negative charge, and retention moves to match.
The class that is not covalent at all
Aggregation involves no wrong molecules. The right ones have simply associated into dimers, larger oligomers, or in bad cases insoluble particulates. Hydrophobic sequences and beta-sheet-prone sequences are the usual candidates.
A reverse-phase purity figure is worse at catching aggregation than at catching anything else here, because the acidic, organic-rich conditions of a standard run tend to dissociate aggregates on the way through. A peptide can thus report high purity while remaining substantially aggregated in aqueous buffer, which is the environment the assay actually runs in. In practice the signal is turbidity or visible particulates in a solution that ought to be clear, and that is a solubility observation rather than an analytical result.
Applying this to a report
- One impurity peak at 2% and twenty peaks at 0.1% describe different situations. The former is a single identifiable species; the latter is process noise.
- Mass below target by a residue mass indicates deletion. A ladder of masses indicates truncation. Mass above target indicates deprotection failure or oxidation.
- Where the sequence contains methionine, cysteine or tryptophan, storage conditions warrant as much attention as the certificate does.
- No impurity peak will represent aggregation. That one reveals itself in the vial.
- Measurements at 214 nm and 280 nm are not interchangeable, and impurities without aromatic residues are under-counted at the longer wavelength. See why two certificates can disagree.
An impurity profile is not inherently cause for alarm. No supplier’s synthetic peptides are pure substances; what matters is whether the profile is understood and whether it holds steady from lot to lot. A supplier who publishes the trace and not merely the number is one you can put that question to. Further reading: third-party vs in-house testing and how HPLC and mass spectrometry verify purity.
ExoLabz supplies compounds for laboratory research use only. Nothing here constitutes medical advice or any suggestion of human or veterinary use. Where third-party reports have been obtained, they are published on our certificates of analysis page.
